182 related articles for article (PubMed ID: 6309203)
1. Haemodynamic, hormonal, and electrolyte effects of enalapril in heart failure.
Fitzpatrick D; Nicholls MG; Ikram H; Espiner EA
Br Heart J; 1983 Aug; 50(2):163-9. PubMed ID: 6309203
[TBL] [Abstract][Full Text] [Related]
2. Acute haemodynamic, hormonal and electrolyte effects and short-term clinical response to enalapril in heart failure.
Fitzpatrick D; Nicholls MG; Ikram H; Espiner EA
J Hypertens Suppl; 1983 Oct; 1(1):147-53. PubMed ID: 6100604
[TBL] [Abstract][Full Text] [Related]
3. Effects of enalapril in heart failure: a double blind study of effects on exercise performance, renal function, hormones, and metabolic state.
Cleland JG; Dargie HJ; Ball SG; Gillen G; Hodsman GP; Morton JJ; East BW; Robertson I; Ford I; Robertson JI
Br Heart J; 1985 Sep; 54(3):305-12. PubMed ID: 2994698
[TBL] [Abstract][Full Text] [Related]
4. Effects of two different enalapril dosages on clinical, haemodynamic and neurohumoral response of patients with severe congestive heart failure.
Pacher R; Stanek B; Globits S; Berger R; Hülsmann M; Wutte M; Frey B; Schuller M; Hartter E; Ogris E
Eur Heart J; 1996 Aug; 17(8):1223-32. PubMed ID: 8869864
[TBL] [Abstract][Full Text] [Related]
5. The renin-angiotensin system in refractory heart failure: clinical, hemodynamic and hormonal effects of captopril and enalapril.
Turini GA; Waeber B; Brunner HR
Eur Heart J; 1983 Jan; 4 Suppl A():189-97. PubMed ID: 6301835
[TBL] [Abstract][Full Text] [Related]
6. Clinical and hemodynamic experience with enalapril in congestive heart failure.
Cody RJ
Am J Cardiol; 1985 Jan; 55(2):36A-40A. PubMed ID: 2981464
[TBL] [Abstract][Full Text] [Related]
7. Enalapril (MK-421), a new angiotensin-converting enzyme inhibitor. Acute and chronic effects in heart failure.
Dunkman WB; Wilen M; Franciosa JA
Chest; 1983 Nov; 84(5):539-45. PubMed ID: 6313304
[TBL] [Abstract][Full Text] [Related]
8. Haemodynamic, hormonal, and electrolyte responses to captopril in resistant heart failure.
Maslowski AH; Ikram H; Nicholls MG; Espiner EA
Lancet; 1981 Jan; 1(8211):71-4. PubMed ID: 6109121
[TBL] [Abstract][Full Text] [Related]
9. Hormonal and metabolic effects of angiotensin converting enzyme inhibitors. Possible differences between enalapril and captopril.
Atlas SA; Case DB; Yu ZY; Laragh JH
Am J Med; 1984 Aug; 77(2A):13-7. PubMed ID: 6089554
[TBL] [Abstract][Full Text] [Related]
10. Enalapril in treatment of hypertension with renal artery stenosis. Changes in blood pressure, renin, angiotensin I and II, renal function, and body composition.
Hodsman GP; Brown JJ; Cumming AM; Davies DL; East BW; Lever AF; Morton JJ; Murray GD; Robertson JI
Am J Med; 1984 Aug; 77(2A):52-60. PubMed ID: 6089557
[TBL] [Abstract][Full Text] [Related]
11. Enalapril: a new angiotensin-converting enzyme inhibitor in chronic heart failure: acute and chronic hemodynamic evaluations.
DiCarlo L; Chatterjee K; Parmley WW; Swedberg K; Atherton B; Curran D; Cucci M
J Am Coll Cardiol; 1983 Nov; 2(5):865-71. PubMed ID: 6313787
[TBL] [Abstract][Full Text] [Related]
12. Acute and long-term response to enalapril in congestive failure.
Kjekshus JK; Søyland E; Dickstein K; Abrahamsen AM; Gundersen T
Br J Clin Pharmacol; 1984; 18 Suppl 2(Suppl 2):169S-174S. PubMed ID: 6099734
[TBL] [Abstract][Full Text] [Related]
13. Evaluation of a long-acting converting enzyme inhibitor (enalapril) for the treatment of chronic congestive heart failure.
Cody RJ; Covit AB; Schaer GL; Laragh JH
J Am Coll Cardiol; 1983 Apr; 1(4):1154-9. PubMed ID: 6187789
[TBL] [Abstract][Full Text] [Related]
14. Enalapril in the treatment of hypertension with renal artery stenosis.
Hodsman GP; Brown JJ; Cumming AM; Davies DL; East BW; Lever AF; Morton JJ; Murray GD; Robertson I; Robertson JI
Br Med J (Clin Res Ed); 1983 Nov; 287(6403):1413-7. PubMed ID: 6315126
[TBL] [Abstract][Full Text] [Related]
15. Neurohormonal and clinical responses to high- versus low-dose enalapril therapy in chronic heart failure.
Tang WH; Vagelos RH; Yee YG; Benedict CR; Willson K; Liss CL; Fowler MB
J Am Coll Cardiol; 2002 Jan; 39(1):70-8. PubMed ID: 11755289
[TBL] [Abstract][Full Text] [Related]
16. Stability and inter-relationships of hormone, haemodynamic and electrolyte levels in heart failure in man.
Fitzpatrick MA; Nicholls MG; Ikram H; Espiner EA
Clin Exp Pharmacol Physiol; 1985; 12(2):145-54. PubMed ID: 3891172
[TBL] [Abstract][Full Text] [Related]
17. Increase in vasoactive intestinal polypeptides (VIP) by the angiotensin converting enzyme (ACE) inhibitor lisinopril in congestive heart failure. Relation to haemodynamic and hormonal changes.
Woie L; Dickstein K; Kaada B
Gen Pharmacol; 1987; 18(6):577-87. PubMed ID: 2822521
[TBL] [Abstract][Full Text] [Related]
18. Acute hemodynamic and hormonal effects of lisinopril (MK-521) in congestive heart failure.
Dickstein K; Aarsland T; Woie L; Abrahamsen AM; Fyhrquist F; Cummings S; Gomex HJ; Hagen E; Kristianson K
Am Heart J; 1986 Jul; 112(1):121-9. PubMed ID: 3014850
[TBL] [Abstract][Full Text] [Related]
19. Hemodynamic and clinical response to enalapril, a long-acting converting-enzyme inhibitor, in patients with congestive heart failure.
Levine TB; Olivari MT; Garberg V; Sharkey SW; Cohn JN
Circulation; 1984 Mar; 69(3):548-53. PubMed ID: 6319045
[TBL] [Abstract][Full Text] [Related]
20. Captopril versus enalapril maleate: a comparison of antihypertensive and hormonal effects.
Lewis RA; Baker KM; Ayers CR; Weaver BA; Lehman MR
J Cardiovasc Pharmacol; 1985; 7 Suppl 1():S12-5. PubMed ID: 2580164
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]